Profil
Gunnar F.
Kaufmann worked as Senior VP-Immunotherapy & Head-Research at Sorrento Therapeutics, Inc. from 2012 to 2019.
He then worked as Chief Scientific Officer at Oncternal Therapeutics, Inc. from 2019 to 2023.
Kaufmann holds a doctorate degree from The Scripps Research Institute, an undergraduate degree from Philipps University of Marburg, and a graduate degree from the University of Greifswald.
Anciens postes connus de Gunnar Kaufmann
| Sociétés | Poste | Fin |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 14/06/2023 |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
Formation de Gunnar Kaufmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Greifswald
University of Greifswald Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
















